1-6 of 6
half-life
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

New therapies for hemophilia

Steven W. Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 650–656.
https://doi.org/10.1182/asheducation-2016.1.650
Published: 2016
Journal Articles

What is the role of an extended half-life product in immune tolerance induction in a patient with severe hemophilia A and high-titer inhibitors?

Maissaa Janbain, Steven Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 648–649.
https://doi.org/10.1182/asheducation-2016.1.648
Published: 2016
Journal Articles

The long and short of it: using the new factor products

Amy Dunn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 26–32.
https://doi.org/10.1182/asheducation-2015.1.26
Published: 2015
Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.
https://doi.org/10.1182/asheducation-2013.1.44
Published: 2013
Journal Articles

Biological Rationale for New Drugs in the Bleeding Disorders Pipeline

Patrick F. Fogarty
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 397–404.
https://doi.org/10.1182/asheducation-2011.1.397
Published: 2011
Journal Articles

Hemophilia: New Protein Therapeutics

Steven W. Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 203–209.
https://doi.org/10.1182/asheducation-2010.1.203
Published: 2010